Market Place
Sourcing Support
All News #Library
Biotech
Sun Pharma Advances New Phase III Study In Soft Tissue Sarcoma
07 Apr 2026 //
INDPHARMAPOST
Sun Pharma Announces US FDA Acceptance of sBLA for ILUMYA
16 Mar 2026 //
PR NEWSWIRE
U.S. Patent Office Invalidates Sun Pharma Patent 11,697,028
26 Feb 2026 //
GLOBENEWSWIRE
Sun Pharma Announces UNLOXCYT for Advanced aCSCC Carcinoma
15 Jan 2026 //
PR NEWSWIRE
Sun Pharma Launches Ilumya For Psoriasis Treatment In India
01 Dec 2025 //
ECONOMICTIMES
Sun Pharma Receives FDA Label Update Approval for Unloxcyt
26 Nov 2025 //
EXPRESSPHARMA
Sun Pharma’s phase 3 clinical studies evaluating ILUMYA
21 Jul 2025 //
EXPRESSPHARMA
Sun Pharma Completes its Acquisition of Checkpoint Therapeutics
30 May 2025 //
PR NEWSWIRE
Music Icon Art Garfunkel Shares Psoriasis Experience with Sun Pharma
04 Apr 2025 //
PR NEWSWIRE
Sun Pharma to Acquire Checkpoint Therapeutics
10 Mar 2025 //
REUTERS
Ilumya Effective In Moderate-To-Severe Nail Psoriasis At AAD 2025
07 Mar 2025 //
PR NEWSWIRE
Incyte wins injunction to block Sun`s Leqselvi launch
05 Nov 2024 //
FIERCE PHARMA
Sun Pharma specialty drug Tildrakizumab makes it to China`s reimbursement list
13 Dec 2023 //
ECONOMIC TIMES
Sun Pharma joins hands with WOTR to create water harvesting capacity
13 Nov 2023 //
INDIAN PHARMA POST
Sun Pharma gets China NMPA approval for ILUMETRI
30 May 2023 //
EXPRESSPHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.